1. What are some of the principles of effective treatment for substance abuse and dependence?
2. Could the public associate a valuable medicinal agent (i.e., a medicine) with the dark world of doping and performance-enhancing drugs? Even worse, could some people accuse these companies of developing drugs that could be misused by athletes as a way of enhancing sales? Discuss the implications.
3. What are the behavioral symptoms of marijuana use?
4. Discuss sleep aids and cough-and-cold remedies as some of the other classes of over-the-counter drugs.
5. Relate the biomedical model of mental illness to the development of psychiatric drugs.
6. Discuss the components of school-based substance-abuse prevention programs that have worked in the past
7. Discuss the importance of different sociocultural filters for effective substance-abuse prevention.
8. Examine the importance of family systems in substance-abuse prevention attempts.
9. Analyze the challenges in designing effective substance-abuse treatment programs.
10. Based on our current research, who is at greatest risk for alcohol abuse or dependence?
2. Could the public associate a valuable medicinal agent with the dark world of doping and performance-enhancing drugs? Even worse, could some people accuse these companies of developing drugs that could be misused by athletes as a way of enhancing sales? Discuss the implications.
Yes, the public can absolutely associate a valuable medicinal agent with the "dark world of doping," and this can have significant implications for pharmaceutical companies. The public may see these companies as being complicit in the misuse of their products, even if a drug was originally developed for a legitimate medical purpose. For example, Erythropoietin (EPO), a medicine used to treat anemia in cancer and kidney patients, became notorious for its misuse by endurance athletes to increase their red blood cell count. This dual-use scenario can create a public perception that the company is knowingly developing drugs that could be diverted for performance enhancement, potentially for financial gain.
The implications are serious. First, it can severely damage a company's reputation and lead to public distrust. This can result in decreased sales for their legitimate products and a tarnished public image. Second, it can attract increased scrutiny from regulatory bodies and anti-doping agencies, leading to stricter regulations, drug monitoring, and potentially legal challenges. Lastly, it raises ethical dilemmas for pharmaceutical companies. While they have a responsibility to develop life-saving and health-improving medicines, they also have a moral obligation to prevent the misuse of those products. The challenge lies in balancing these responsibilities when a drug's legitimate use could be a gateway to illicit misuse.
3. What are the behavioral symptoms of marijuana use?
The behavioral symptoms of marijuana use, particularly during intoxication, can vary but commonly include:
Impaired motor coordination: Difficulty with balance and movement.
Euphoria: A feeling of intense happiness or well-being.
Anxiety and paranoia: Feelings of unease, fear, or suspicion.
A sensation of slowed time: The perception that time is moving more slowly.
Impaired judgment: Poor decision-making.
Social withdrawal: A tendency to isolate oneself from others.
Increased appetite: Often referred to as "the munchies."
Sample Answer
What are some of the principles of effective treatment for substance abuse and dependence?
Effective treatment for substance abuse is guided by several core principles. It's crucial to understand that no single treatment approach is suitable for everyone; treatment must be individualized and readily available. Effective treatment also needs to address the individual's multiple needs—not just their drug use, but also any associated medical, psychological, social, vocational, and legal issues. The individual's treatment plan should be continually assessed and modified as needed. Staying in treatment for an adequate period is critical for long-term effectiveness, as research suggests a threshold of significant improvement is often reached at about three months. Behavioral therapies, such as individual or group counseling, are essential components, and for many patients, medications are an important element, particularly when combined with counseling. Integrated treatment for coexisting mental disorders and substance abuse disorders is also vital.